Navigation Links
US Proton Therapy Market Analysis to 2017
Date:6/24/2013

DUBLIN, June 24, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/h6nxfj/us_proton_therapy) has announced the addition of the "US Proton Therapy Market Analysis to 2017" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

According to most Oncologists, about 60% of all cancer patients undergo some sort of radiation therapy during their course of treatment. Despite advances in technology for radiation therapy, a majority of these patients suffer from side effects of traditional radiation treatment. Currently prevalent radio therapy methods like X-Ray/IMRT etc. also cost pretty high in the long run.

In this context, Proton Therapy, the latest innovation in the field of radio-oncology, answers all the problems related to radiation therapy. The technology is expected to eventually replace the traditional methods of radiotherapy in the future and thus, holds immense market potential for players in the industry.

The report, US Proton Therapy Market Analysis to 2017, presented in 30 slides, provides an extensive research and in-depth analysis of the current status and future outlook of the US proton therapy market. A thorough analysis has been carried on the various parameters concerned with the existing and upcoming proton therapy centers in the US. The report offers state-wise potential for the industry players and provides conservative market estimates till 2017.

As per our research, Procure is the leading service provider and accounts for the major chunk of proton therapy market in the US. From an equipment provider's perspective, IBA has the maximum proton accelerators installed in the facilities. The report further delves into the anticipated t
'/>"/>

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Proton Pharma and Rottapharm Switch to Cloud-Based Veeva CRM for its Flexibility to Meet Unique Local Needs in Greece
2. Life Technologies Begins Shipping Ion Proton System
3. Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare
4. Genomic Research Service Provider DNA Link Purchases 10 Ion Proton Sequencers
5. Concord Medical Acquires Ownership Interest in MD Anderson Cancer Center Proton Therapy Center
6. Apollo Hospitals to Establish the First Proton Therapy Center for Cancer Treatment to Serve Over 3.5 Billion People
7. Pioneering Medical Technology Company, Optivus Proton Therapy, Inc., Celebrates 20th Anniversary
8. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
9. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
10. IRIDEX Introduces Non-Invasive MicroPulseâ„¢ Therapy for Glaucoma
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... of, collaboration with investigators worldwide to develop new treatments for ... diverse forms of cancer ... on relapse rate of patients with early-stage breast cancer, - Four oral ... results of RECORD-1 study in renal cell ...
... Mich. and TOULOUSE, France, May 15 ... company,developing HDL-related compounds for the treatment of ... has completed a Phase I,clinical trial for ... candidates.,CER-002 is a peroxisome proliferator-activated receptor (PPAR),delta-specific ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2
(Date:4/24/2014)... spectrum disorders (ASD), resides in genes that are part ... the Icahn School of Medicine at Mount Sinai, who ... the United States and throughout the world. The ... in Autism Spectrum Disorders," was first published online in ... April 24. , ASD affects about one percent ...
(Date:4/24/2014)... at UT Southwestern Medical Center previously discovered that the ... adult heart lacks this ability. New research by the ... its incredible regenerative capability in adulthood, and the answer ... It is well-known that a major function of the ... But at the same time, oxygen is a highly ...
(Date:4/24/2014)... during and after colorectal surgery cut hospital stays by ... who led a study of the approach at Duke ... easier on patients before surgery, doing away with the ... After surgery, patients are encouraged to eat and move ... , Among findings published in the May 2014 issue ...
(Date:4/24/2014)... and the relevance of palliation in advanced cancer ... controlled trials (RCTs). This is the result of ... and Efficiency in Health Care (IQWiG), which has ... with external experts, IQWiG analysed studies on four ... melanoma, and pancreatic cancer. For this purpose, the ...
(Date:4/24/2014)... first in the world to discover a gene mutation ... , Ameloblastoma is an odontogenic tumour with a high ... found in the posterior of the lower jaw. Ameoloblastomas ... in the jaws as well as loss of several ... for surgery and the recurrence of ameloblastoma, but finding ...
Breaking Medicine News(10 mins):Health News:Genetic alterations in shared biological pathways as major risk factor for ASD 2Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3
... , ANNAPOLIS, Md., July 27 ... biodefense company developing medical countermeasures against biological and chemical threats, ... issuance of 2-year, 10% unsecured senior convertible notes ("Notes") and ... approximately $19.3 million. , , In connection ...
... , , ... How can hospitals build sustainable physician alignment? While hospitals ... few physician-relationship management programs demonstrate value. A new "thought ... Ensuring the Stability and Vitality of Today,s Hospitals," illustrates ...
... , FRANKLIN, Mass., July 27 ... focused on innovative cardiac and vascular medical device-based technologies, today ... fluid balancing capabilities provided by RenalGuard(R) from the Canadian Intellectual ... company,s first patent for RenalGuard in Canada. , , ...
... reveals more about how information is processed, stored in the ... read her name, your Oprah neuron will probably rev up. ... neurons in the brain,s hippocampus activate when people recognize a ... distorted or presented in less than perfect fashion. , "Different ...
... MINNEAPOLIS, July 27 Premier Visiting Nurse, part ... entered into a business relationship with Cardiocom (R) ... chronic illness. Cardiocom, the Experts in Telehealth(SM), is ... of award-winning telehealth solutions. , , ...
... , , BOSTON, July 27 ... and information management solutions, today announced a new contract with Booth ... use the AMICAS ONE Suite(TM) as its end-to-end radiology software solution, ... care. , , (Logo: ...
Cached Medicine News:Health News:PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants 2Health News:PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants 3Health News:PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants 4Health News:Proper Physician-Relationship Management Ensures Hospital Stability and Vitality 2Health News:Canada Grants PLC Systems First Patent for RenalGuard(R) 2Health News:Famous Names Get Single Neurons Fired Up 2Health News:Premier Visiting Nurse Selects Cardiocom Telehealth Technology 2Health News:Booth Radiology Extends and Elevates Partnership With AMICAS 2Health News:Booth Radiology Extends and Elevates Partnership With AMICAS 3
Fine angled tips ideal for grasping delicate capsule. Angled 12 mm shafts with iris stop allows ease of movement in the anterior chamber. Flat handle with dull finish. Manufactured in titanium....
Gently curved shaft with 2 mm platform ideal for performing capsulorhexis through a tunnel incision. Flat handle with dull finish....
Fine angled 12 mm shafts and iris stop. Round handle for fingertip rotational control. Dull finish....
Gently curved jaws with fine angled sharp tips for puncture and grasping the capsule. Round handle is excellent for precise finger tip control. Made in titanium....
Medicine Products: